The antibody HEB-29 reacts with human blood group B. The specifity of the antibody HEB-29 was confirmed by comparison of specifity and reactivity to standard reagent using >5000 samples of blood.
Kreuzreaktivität (Details)
Human
Aufreinigung
Hybridoma culture supernatant concentrated by membrane ultrafiltration.
Immunogen
Mixture of erythrocytes of group B and glycoprotein fraction isolated from saliva of secretors with blood group B.
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Handhabung
Do not freeze. Avoid prolonged exposure to light.
Lagerung
4 °C
Informationen zur Lagerung
Store at 2-8°C. Do not freeze.
Vanák, Drímalová, Smyslová, N?mec, Viklický, Wisniewski: "Detection of blood group A antigen expression in human colon cancer using monoclonal antibodies with different specificities." in: Neoplasma, Vol. 36, Issue 4, pp. 479-88, (1989) (PubMed).
N?mec, Drímalová, Horejsí, Vanák, Bártek, Viklický: "Murine monoclonal antibodies to human A erythrocytes: differential reactivity with N-acetyl-D-galactosamine." in: Vox sanguinis, Vol. 52, Issue 1-2, pp. 125-8, (1987) (PubMed).